Compared with the WLC condition , EA produced significant improvements in fatigue ( P = .0095 ) , anxiety ( P = .044 ) , and depression ( P = .015 ) and a nonsignificant improvement in sleep disturbance ( P = .058 ) during the 12-week intervention and follow-up period .